BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Association of Pulmonary Advanced Practice Providers (APAPP) - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Association of Pulmonary Advanced Practice Providers (APAPP)
X-ORIGINAL-URL:https://www.pulmapp.com
X-WR-CALDESC:Events for Association of Pulmonary Advanced Practice Providers (APAPP)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Krasnoyarsk
BEGIN:STANDARD
TZOFFSETFROM:+0700
TZOFFSETTO:+0700
TZNAME:+07
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Krasnoyarsk:20210414T183000
DTEND;TZID=Asia/Krasnoyarsk:20210414T193000
DTSTAMP:20260412T084625
CREATED:20210326T054544Z
LAST-MODIFIED:20220812T173053Z
UID:6138-1618425000-1618428600@www.pulmapp.com
SUMMARY:Experts Discuss: 2020 NTM Guideline Recommendations and Treatment Options for MAC Lung Disease
DESCRIPTION:The webinar will cover the following topics: \n\nDiagnostic criteria\nTesting recommendations\nTreatment considerations and recommendations\nManagement and monitoring
URL:https://www.pulmapp.com/event/experts-discuss-2020-ntm-guideline-recommendations-and-treatment-options-for-mac-lung-disease/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/03/BLAH.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210415
DTEND;VALUE=DATE:20210418
DTSTAMP:20260412T084625
CREATED:20210117T075321Z
LAST-MODIFIED:20241029T031331Z
UID:6044-1618444800-1618703999@www.pulmapp.com
SUMMARY:Mayo Clinic Sleep Medicine Update
DESCRIPTION:Mayo Clinic Sleep Medicine Update is the first CME course from Mayo Clinic pertaining entirely to sleep medicine. This livestream course is designed for practitioners in the field of sleep medicine including established providers\, new practitioners\, physician assistants and nurse practitioners. Drawing on the wealth of cases across the three geographic Mayo Clinic sleep centers\, our expert faculty mirror the multidisciplinary approach to the practice of sleep medicine. This case-based format and open question and answer sessions provide a unique and practical resource for sleep medicine providers. A pre-course session on fundamentals of sleep medicine will occur Thursday\, April 15\, 2021. \nCourse Highlights: \n\nPre-course on fundamentals of sleep medicine – Thursday\, April 15\, 2021\nCase-based\, interactive model drawing on the wealth of cases seen across Mayo Clinic sleep centers\nDedicated time for questions and discussion with multidisciplinary faculty\nPractical insights that can be applied immediately to daily practice\nAccess to course recordings for one year
URL:https://www.pulmapp.com/event/mayo-clinic-sleep-medicine-update/
LOCATION:Virtual
CATEGORIES:Sleep
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/Mayo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210415
DTEND;VALUE=DATE:20210418
DTSTAMP:20260412T084625
CREATED:20210314T095515Z
LAST-MODIFIED:20241029T031358Z
UID:6111-1618444800-1618703999@www.pulmapp.com
SUMMARY:Mayo Clinic Sleep Medicine Update Livestream
DESCRIPTION:Course Directors: Brendon M. Colaco\, M.B.B.S.\, Timothy I. Morgenthaler\, M.D.\, and  Muhammad (Adeel) A. Rishi\, M.B.B.S. \nApril 15 – 17\, 2021 – Livestream\n8:00 a.m. – 3:00 p.m. CST \nMayo Clinic Sleep Medicine Update is the first CME course from Mayo Clinic pertaining entirely to sleep medicine. This livestream course is designed for practitioners in the field of sleep medicine including established providers\, new practitioners\, physician assistants and nurse practitioners. Drawing on the wealth of cases across the three geographic Mayo Clinic sleep centers\, our expert faculty mirror the multidisciplinary approach to the practice of sleep medicine. This case-based format and open question and answer sessions provide a unique and practical resource for sleep medicine providers. A pre-course session on fundamentals of sleep medicine will occur Thursday\, April 15\, 2021. \nCourse Highlights: \n\nPre-course on fundamentals of sleep medicine – Thursday\, April 15\, 2021\nCase-based\, interactive model drawing on the wealth of cases seen across Mayo Clinic sleep centers\nDedicated time for questions and discussion with multidisciplinary faculty\nPractical insights that can be applied immediately to daily practice\nAccess to course recordings for one year\n\nLearning Objectives\n\n\n\nUpon completion of this activity\, participants should be able to: \n\nExamine phrenic nerve stimulation in management for central and complex sleep apnea\nDifferentiate modalities and pathways for positive airway pressure therapy in complex sleep apnea\, chronic respiratory failure and obesity hypoventilation syndrome\nRecognize operations of sleep practice and laboratory in the era of COVID\nAnalyze tele technology in post COVID practice of sleep medicine including opportunities\, challenges\, and successes\nReview wearable sleep technology and its use in diagnostics and management\nIdentify strategies in managing insomnia\nExamine the effectiveness and dosing of new medications in hypersomnia\nReview medication and behavioral strategies in the management of refractory restless legs syndrome\nReview updates in research and management of REM Behavior Disorder (RBD) and neurodegenerative diseases
URL:https://www.pulmapp.com/event/mayo-clinic-sleep-medicine-update-livestream/
LOCATION:Virtual
CATEGORIES:Sleep
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/Mayo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Krasnoyarsk:20210415T213000
DTEND;TZID=Asia/Krasnoyarsk:20210415T223000
DTSTAMP:20260412T084625
CREATED:20210326T054914Z
LAST-MODIFIED:20210326T054914Z
UID:6140-1618522200-1618525800@www.pulmapp.com
SUMMARY:Experts Discuss: 2020 NTM Guideline Recommendations and Treatment Options for MAC Lung Disease
DESCRIPTION:The webinar will cover the following topics: \n\nDiagnostic criteria\nTesting recommendations\nTreatment considerations and recommendations\nManagement and monitoring
URL:https://www.pulmapp.com/event/experts-discuss-2020-ntm-guideline-recommendations-and-treatment-options-for-mac-lung-disease-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/03/BLAH.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210425
DTEND;VALUE=DATE:20210430
DTSTAMP:20260412T084625
CREATED:20210217T071451Z
LAST-MODIFIED:20241029T032358Z
UID:6089-1619308800-1619740799@www.pulmapp.com
SUMMARY:Pulmonary and Critical Care Medicine 2021
DESCRIPTION:Participants will get updates to optimize care of patients with: Unexplained chronic cough\, occupational lung disease\, COPD and interventional bronchoscopy\, asthma\, NSCLC\, lung adenocarcinoma and proteogenomics\, sleep apnea\, GERD in pulmonology\, sepsis\, ARDS\, interstitial lung disease\, IPF\, hypersensitivity pneumonitis\, pneumonia\, sarcoidosis\, bronchiectasis\, cystic fibrosis\, pulmonary microbiome\, mycobacterial disease\, pulmonary hypertension\, thromboembolism\, lung transplantation\, patterns and insights from chest radiology\, thoracic ultrasound in critical care\, noninvasive respiratory support for acute respiratory failure\, novel ventilator modes\, palliative care in advanced lung disease. \nSpecial Half-Day Updates: \n\nCare of COVID-19 and Post-COVID-19 Patients (clinical practices employed at MGH in both inpatient and outpatient settings of responding to the virus\, effective infection control measures\, clinical trials results)\nSleep Medicine for the Pulmonologist (including new technologies\, reimbursement\, telemedicine)\n\n50.75 AMA PRA Category 1 Credits™ \nDate: April 25-29\, 2021
URL:https://www.pulmapp.com/event/pulmonary-and-critical-care-medicine-2021/
LOCATION:Virtual
CATEGORIES:Critical Care
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/Harvard.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210427
DTEND;VALUE=DATE:20210501
DTSTAMP:20260412T084625
CREATED:20201203T135716Z
LAST-MODIFIED:20201203T135716Z
UID:6018-1619481600-1619827199@www.pulmapp.com
SUMMARY:ISHLT: 41st Annual International Meeting and Scientific Sessions
DESCRIPTION:The International Society for Heart and Lung Transplantation will host the 41st Annual Meeting & Scientific Sessions in Toronto\, Canada\, April 27-30…and virtually. ISHLT2021 is being planned as a hybrid event. We look forward to connecting with the ISHLT community in Toronto and around the world\, both in-person and online. \nFor those attending the even in-person\, the health and safety of ISHLT members\, attendees\, exhibitors\, and staff is the highest priority of ISHLT and the Metro Toronto Convention Centre. We will follow strict guidelines and protocols developed in consultation with Toronto Public Health and the Ontario Ministry of Health to ensure safety and cleanliness measures are implemented in the meeting space\, exhibit hall\, and common areas of the Metro Toronto Convention Centre. We will share detailed safety guidelines with you\, including but not limited to\, social distancing measures\, wearing of face coverings\, managing attendee flow and room capacities\, and cleanliness. \nISHLT’s Annual Meetings are attended by the world’s premier specialists treating advanced heart and lung disease. Faculty and participation is organized around the care team\, ISHLT’s unique interdisciplinary\, multi-national focus. \nRegistration will open in November 2020. More information will be coming soon.
URL:https://www.pulmapp.com/event/ishlt-41st-annual-international-meeting-and-scientific-sessions/
LOCATION:Metro Toronto Convention Center/Hybrid Virtual Conference\, Toronto\, Canada
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2020/12/ISHLT.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Krasnoyarsk:20210429T150000
DTEND;TZID=Asia/Krasnoyarsk:20210429T170000
DTSTAMP:20260412T084625
CREATED:20210405T075412Z
LAST-MODIFIED:20210405T075412Z
UID:6145-1619708400-1619715600@www.pulmapp.com
SUMMARY:Impact of COVID-19 on Children
DESCRIPTION:Children have been less impacted by the pandemic than adults\, but its direct and indirect effects still have been significant. Additionally\, a newly identified hyperinflammatory syndrome\, MIS-C\, has caused multisystem critical illness in some children. In this webinar\, we will review the impacts of COVID-19 on children\, including the clinical manifestations and potential etiologies of MIS-C and the indirect effects of the pandemic.
URL:https://www.pulmapp.com/event/impact-of-covid-19-on-children/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/04/CHEST-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210430
DTEND;VALUE=DATE:20210503
DTSTAMP:20260412T084625
CREATED:20210217T071812Z
LAST-MODIFIED:20250123T181827Z
UID:6090-1619740800-1619999999@www.pulmapp.com
SUMMARY:American Association for Thoracic Surgery (AATS) 101st Annual Meeting Featuring Aortic Symposium and Mitral Conclave
DESCRIPTION:Event Overview\nTo create the best possible outcomes for cardiothoracic patients\, surgeons must come together to have discussions\, ask hard questions\, hear new perspectives\, and build on each other’s work. \nSave the date for the virtual AATS 101st Annual Meeting\, featuring the Aortic Symposium and Mitral Conclave\, April 30 – May 2\, 2021\, where you will learn from experts on how they optimize and even revolutionize exceptional treatment. Surgeons are the creators and disseminators of new knowledge—and with their leadership\, medical teams have the tools they need to advance patient care. \nReasons to participate: \n\nImmerse yourself and your team with cutting-edge information from diverse expert speakers;\nChoose from multiple parallel tracks that focus on specific aspects of adult cardiac\, thoracic\, and congenital specialties;\nParticipate in panel discussions where surgeons from around the world share the challenges and solutions being implemented;\nTake action and learn how to apply wellness – not only individual wellness\, but the wellness of our specialty and the global community at large;\nEarn Continuing Medical Education (CME) credits to advance your career.\n\nRegistration will open in Early 2021.
URL:https://www.pulmapp.com/event/american-association-for-thoracic-surgery-aats-101st-annual-meeting-featuring-aortic-symposium-and-mitral-conclave/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/02/aats-sh.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210506
DTEND;VALUE=DATE:20210508
DTSTAMP:20260412T084625
CREATED:20210217T072143Z
LAST-MODIFIED:20250802T013727Z
UID:6093-1620259200-1620431999@www.pulmapp.com
SUMMARY:11th Annual Pediatric Asthma Conference
DESCRIPTION:Date & Location: Thursday\, May 6\, 2021\, 9:55 AM – Friday\, May 7\, 2021\, 3:40 PM\n\nCredits: AMA PRA Category 1 Credits™ (8.50 hours)\, ANCC Contact Hour(s) (8.50 hours) \n\nOverview: Presented Virtually From: Nationwide Children’s Hospital Conference Center\n\nKeynote Speakers:\nDavid Lang\, MD\nProfessor of Medicine and Chair\, Department of Allergy and Clinical Immunology\, Respiratory Institute\, Cleveland Clinic\, Cleveland\, Ohio \nJay M. Portnoy\, MD\nMedical Director\, Telemedicine; Allergist\, Section of Allergy/Asthma/Immunology\, Children’s Mercy Hospital\, Kansas City\, Missouri; Professor of Pediatrics\, University of Missouri-Kansas City School of Medicine \nHighlights:\n• Transition of Care: Pediatric to Adult\n• Optimizing Telemedicine for Asthma Care\n• Interactive Asthma Simulation\n• Managing Difficult Conversations to Create Positive Outcomes \nIntended Audience: Pediatricians\, Family Practitioners\, Nurses\, Respiratory Therapists\, Social Workers\, Pharmacists and Clinical Staff from hospital\, urgent care\, primary care\, and school facilities with students/patients who have asthma and allergies. \nObjectives:\n\nDiscuss transition of care (pediatric to adult) management strategies for allergy and asthma patients.\nIdentify novel approaches of allergy and asthma management for patients with challenging needs.\nUtilize treatment options and resources for the patient and family affected by allergic disease and asthma.\n\nRegistration:\n\n\n\n\n\n\nEarly Bird Registration BOTH DAYS Until 3/7\n$100\n\n\nRegular Registration BOTH DAYS \n$125\n\n\n\n\n\n\nEarly Bird Registration FRI ONLY Until 3/7\n$55\n\n\nRegular Registration FRI ONLY \n$65\n\n\n\n\n\n\nEarly Bird Registration PRECON ONLY Until 3/7\n$45\n\n\nRegular Registration PRECON ONLY\n$55\n\n\n\n\n\n\nNCH Employee Registration BOTH DAYS\n$75\n\n\nNCH Employee Registration FRI ONLY\n$45\n\n\nNCH Employee Registration PRECON ONLY\n$35\n\n\n\n\n\n\nFellow/Resident/Student Registration BOTH DAYS\n$60\n\n\nFellow/Resident/Student Registration FRI ONLY\n$35\n\n\nFellow/Resident/Student Registration PRECON ONLY\n$25\n\n\n\nAccreditation: In support of improving patient care\, Nationwide Children’s Hospital is accredited by the American Nurses Credentialing Center (ANCC)\,  the Accreditation Council for Pharmacy Education (ACPE)\, and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for the healthcare team.
URL:https://www.pulmapp.com/event/11th-annual-pediatric-asthma-conference/
LOCATION:Virtual
CATEGORIES:Asthma,Pediatrics
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/02/nationwide_childrens_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210514
DTEND;VALUE=DATE:20210520
DTSTAMP:20260412T084625
CREATED:20210217T072633Z
LAST-MODIFIED:20210217T072633Z
UID:6099-1620950400-1621468799@www.pulmapp.com
SUMMARY:American Thoracic Society (ATS) 2021 International Conference
DESCRIPTION:The ATS International Conference is the place where pulmonary\, critical care\, and sleep professionals\, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition – nearly 14\,000 of these professionals – present\, and learn about the latest advances in the field\, meet with colleagues from around the world\, and strike new collaborations. It is truly where today’s thoracic science meets tomorrow’s care. This international conference is also multidisciplinary. Clinicians and researchers from other fields attend the conference\, thereby enriching conversations that lead to insights that ultimately improve patient care. \n~ 43 AMA PRA Category 1 Credits™ \nDate: May 14-19\, 2021 (Virtual)
URL:https://www.pulmapp.com/event/american-thoracic-society-ats-2021-international-conference/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2021/02/2021-logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210518
DTEND;VALUE=DATE:20210519
DTSTAMP:20260412T084625
CREATED:20210217T072422Z
LAST-MODIFIED:20210217T072422Z
UID:6096-1621296000-1621382399@www.pulmapp.com
SUMMARY:2021 Cystic Fibrosis Education Day
DESCRIPTION:Date & Location\nTuesday\, May 18\, 2021\, 9:00 AM – 1:00 PM \nTarget Audience\nSpecialties – Academic/Research\, Critical Care Medicine\, Dietitians\, Endocrinology\, Diabetes and Metabolism\, Family Practice\, Gastroenterology\, Hepatology and Nutrition\, General Internal Medicine\, General Practice\, Infectious Diseases\, Nurse Practitioner\, Nursing\, Nutrition\, Pharmacist\, Pharmacy Technician\, Physical Therapy\, Physician Assistant\, Physicians\, Psychiatry\, Psychology\, Pulmonary Disease\, Respiratory Therapy\, Social Work\n  \nOverview\nDue to advances in treatment\, patients with cystic fibrosis (CF) are living longer into adulthood. This event serves to provide critical updates on the latest medical advances in holistic care management for adults living with CF. Presentations by experts in the field will include new techniques for airway clearance therapy\, pulmonary exacerbations\, CF-related diabetes\, coordination of care\, and clinical research updates. The event will also include an inter-generational panel of CF patients discussing their life experiences\, treatment approaches\, and coping strategies to promote resilience. \nObjectives: \nAt the conclusion of this activity\, learners will be able to: \n\nIdentify and manage pulmonary exacerbations in CF to maximize lung function across the lifespan.\nDescribe clinical guidelines for care of adult CF patients through interdisciplinary health care teams.\nDiscuss challenges and identify pitfalls in comprehensive care of adults with CF.\nOutline updates in clinical research for CF treatment.\n\nRegistration:\nSelect the register tab above to complete your online registration. Registration will be open through May 13\, 2021. \nThis conference is offered at no cost to all health care professionals\, patients and families in the cystic fibrosis community. Health care professionals interested in continuing education credit for this activity will be able to claim credit for a $20 fee. \n 
URL:https://www.pulmapp.com/event/2021-cystic-fibrosis-education-day/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/02/vcuh_conted_logo_transcript.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210610
DTEND;VALUE=DATE:20210614
DTSTAMP:20260412T084625
CREATED:20210314T092436Z
LAST-MODIFIED:20241029T031405Z
UID:6125-1623283200-1623628799@www.pulmapp.com
SUMMARY:SLEEP 2021
DESCRIPTION:SLEEP is the annual meeting of the Associated Professional Sleep Societies\, LLC (APSS)\, which is a joint venture of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS).\nThe SLEEP meeting provides evidence-based education to advance the science and clinical practice of sleep medicine\, disseminates cutting-edge sleep and circadian research\, promotes the translation of basic science into clinical practice\, and fosters the future of the field by providing career development opportunities at all levels. There is simply no other gathering of sleep professionals anywhere of this scale. The conference is attended by thousands of individuals from all around the world\, all connected by their interest and/or expertise in sleep medicine. Many of these attendees are pioneering leaders in the field. If you are looking to network\, you must attend SLEEP.
URL:https://www.pulmapp.com/event/sleep-2021/
LOCATION:Virtual
CATEGORIES:Sleep
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2021/03/SLEEp.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Krasnoyarsk:20210610T080000
DTEND;TZID=Asia/Krasnoyarsk:20210612T170000
DTSTAMP:20260412T084625
CREATED:20210417T140628Z
LAST-MODIFIED:20210417T140628Z
UID:15132-1623312000-1623517200@www.pulmapp.com
SUMMARY:2021 Alpha-1 National Conference
DESCRIPTION:he Alpha-1 National Conference is the largest annual gathering of Alphas\, their families\, leading healthcare professionals\, and industry in the world. It is a three-day event with educational programs given by national experts and leaders in the Alpha-1 field. The conference provides attendees and exhibitors the opportunity to network and increase their understanding of Alpha-1 and COPD.
URL:https://www.pulmapp.com/event/2021-alpha-1-national-conference/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/04/2021-Alpha-1-Conference-Banner-with-date-1024x262-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210729
DTEND;VALUE=DATE:20210801
DTSTAMP:20260412T084625
CREATED:20210314T092905Z
LAST-MODIFIED:20250802T011208Z
UID:6128-1627516800-1627775999@www.pulmapp.com
SUMMARY:22nd Annual International Lung Cancer Congress
DESCRIPTION:Overview\nThe 22nd Annual International Lung Cancer Congress® will distill the latest data on targeted agents\, immunotherapy\, surgery\, and radiation oncology to provide you with current and practical information on the management of patients with lung cancer. As in previous years\, we will also preview novel agents and strategies with the potential to shape the future of lung cancer therapy. Cutting-edge lectures and extended panel discussions\, along with multidisciplinary tumor boards and interactive question-and-answer sessions\, will provide a unique opportunity for participants to engage with leading international and national experts as they share their perspectives and personal experiences surrounding clinical challenges and ongoing controversies in lung cancer management. \nTarget Audience\nThis educational activity is directed toward medical\, surgical\, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows\, nurse practitioners\, nurses\, physician assistants\, pharmacists\, researchers\, and other health care professionals interested in the treatment of lung cancer are also invited to attend. \nHot Topics for 2021\n\nAdjuvant EGFR-targeted therapy\nChoosing firstline immunotherapy-based regimens\nTargeted agents and the expanding array of oncogenic drivers\nTelemedicine and incorporating technology in the practice of oncology
URL:https://www.pulmapp.com/event/22nd-annual-international-lung-cancer-congress/
LOCATION:Hyatt Regency Huntington Beach\, 21500 Pacific Coast Highway\, Huntington Beach\, California
CATEGORIES:Cancer
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/03/Lung.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210826
DTEND;VALUE=DATE:20210829
DTSTAMP:20260412T084625
CREATED:20210606T091312Z
LAST-MODIFIED:20210606T091312Z
UID:15138-1629936000-1630195199@www.pulmapp.com
SUMMARY:AABIP 2021 Annual Conference
DESCRIPTION:The AABIP 2021 Annual Conference will be taking place on August 26 to 28. This year we will have the chance to explore a new format\, where a fantastic scientific program will intertwine both digital and physical aspects of the meeting. Join us in person in Baltimore\, MD or watch online. \nThe Conference’s new flexible format will enable us to leverage an immersive digital experience\, safeguarding your well-being and facilitating your participation wherever in the world you are based\, while providing dynamic in-person discussions within the community. \nAfter a year of unexpected scenarios and travel restrictions where we were driven to find new possibilities to connect\, we are now well-prepared to fully integrate our digital component. In a sense\, technology traversing physical borders and bringing us together globally provides us all with more opportunities for wider participation and inclusion.
URL:https://www.pulmapp.com/event/aabip-2021-annual-conference/
LOCATION:Baltimore\, MD
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/06/AABIP.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210905
DTEND;VALUE=DATE:20210909
DTSTAMP:20260412T084625
CREATED:20210827T091018Z
LAST-MODIFIED:20210827T091018Z
UID:15169-1630800000-1631145599@www.pulmapp.com
SUMMARY:European Respiratory Society (ERS) International Congress 2021
DESCRIPTION:This virtual annual congress is a showcase of excellence across the entire field of respiratory medicine. \nFormat: Postgraduate courses – week-long virtual events October 11-15 (lecture-based sessions include dedicated time for interaction between participants and faculty; 100 participants per session)\, Challenging Clinical Cases sessions\, Game Zone (interactive space with individual skills stations\, and an online game-based platform)\, HERMES European examinations (knowledge-based and are comprised of 90 multiple-choice questions each)\, Lungs on Fire sessions (led by two discussants who will present the cases to a panel of experts and the audience)\, lunchtime Meet the Expert sessions (an expert will stimulate discussion\, answer questions and offer advice – more personal approach to learning; limited to 40 participants)\, Professional Development workshops (aimed to provide team leaders\, supervisors)\, Skills workshops (32 participants per workshop + fee)\, case-based skills workshops (50 participants per workshop + fee)\, Patient forum (looks at the best ways healthcare professionals can relay information to respiratory patients)\, Respiratory Championship (four teams battling).
URL:https://www.pulmapp.com/event/european-respiratory-society-ers-international-congress-2021/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/08/ERS.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210908
DTEND;VALUE=DATE:20210915
DTSTAMP:20260412T084625
CREATED:20210827T091444Z
LAST-MODIFIED:20250802T011155Z
UID:15172-1631059200-1631663999@www.pulmapp.com
SUMMARY:IASLC 2021 World Conference on Lung Cancer (WCLC21)
DESCRIPTION:This conference will be offered as a safe virtual experience due to COVID-19 pandemic spread. \nThe World Conference on Lung Cancer (WCLC)\, organized by the International Association for the Study of Lung Cancer (IASLC)\, is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. \nThe IASLC’s 2021 meetings will include both live streaming event with virtual interactions and on-demand content
URL:https://www.pulmapp.com/event/iaslc-2021-world-conference-on-lung-cancer-wclc21/
LOCATION:Virtual
CATEGORIES:Cancer
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/08/WCLC21-Logo_0820.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210920
DTEND;VALUE=DATE:20210924
DTSTAMP:20260412T084625
CREATED:20210314T092131Z
LAST-MODIFIED:20250205T201416Z
UID:6122-1632096000-1632441599@www.pulmapp.com
SUMMARY:Aspen Lung Conference
DESCRIPTION:The 63rd Annual Thomas L. Petty Aspen Lung Conference\nWill convene at the Gant Conference Center in Aspen\, Colorado with a virtual/in-person hybrid format. The theme of the conference will be “ARDS in the 21st Century: New Insights into Clinical and Mechanistic Heterogeneity.” \nThe Acute Respiratory Distress Syndrome (ARDS) represents a common syndrome arising from numerous\, heterogeneous\, and often-independent disease processes.  Accordingly\, a single ARDS study drug\, if uniformly applied to all patients regardless of underlying disease pathophysiology\, would likely fail to consistently improve patient outcomes. For clinical studies to overcome this obstacle\, a new appreciation of ARDS mechanistic and phenotypic heterogeneity is required\, enabling future precision medicine approaches to the recognition and treatment of lung injury. \nThe 2021 Thomas L. Petty Aspen Lung Conference will integrate basic\, translational\, and clinical approaches to address the impact of ARDS heterogeneity\, with a focus on (1) understanding the presence and therapeutic significance of ARDS mechanistic and phenotypic subtypes\, (2) exploring multi-cellular and multi-systemic mechanisms responsible for this heterogeneity\, and (3) determining how to best account for disease heterogeneity during clinical trial design and outcome assessment. Heterogeneity within COVID-19 ARDS\, as well as between COVID-19 and non-COVID-19 ARDS\, will also be discussed. \nThis conference will provide an international forum bringing together leading basic\, translational\, and clinical ARDS researchers while welcoming trainees in pulmonology and critical care medicine\, with the goal of identifying shared interests that will lead to more productive research and more effective personalized therapies. Finally\, the varied scientific themes and therapeutic strategies emerging during the conference will be reconciled in a concluding Conference Summary presented by Dr. Thomas Martin (University of Washington).
URL:https://www.pulmapp.com/event/aspen-lung-conference-2/
LOCATION:Aspen\, Colorado\, Aspen\, CO\, United States
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/03/CU.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210923
DTEND;VALUE=DATE:20210925
DTSTAMP:20260412T084625
CREATED:20210827T091824Z
LAST-MODIFIED:20210827T091824Z
UID:15175-1632355200-1632527999@www.pulmapp.com
SUMMARY:Rare Genetic Causes of Bronchiectasis: Paving the Way for Interventional Trials
DESCRIPTION:This conference will bring together clinical and translational investigators in rare genetic causes of bronchiectasis\, including primary ciliary dyskinesia (PCD)\, primary immunodeficiencies (PID)\, alpha-1 anti-trypsin disease (AATD) and cystic fibrosis (CF)\, to discuss preparing for collaborative multicenter clinical trials. In this day and a half-long conference presenters will address critical knowledge gaps in disease pathogenesis\, clinical trial preparedness and overcoming barriers to successful trials in these rare disease patient populations. Speakers will provide state-of-the-art updates on the diagnosis and major sources of morbidity in these conditions\, as well as commonalities and differences in bronchiectasis pathogenesis\, with an emphasis on potential therapeutic targets. Lessons learned from previous clinical trials\, particularly in CF\, will be presented\, in order to capitalize on previous experience as we plan future clinical trials. The strengths and weaknesses of potential clinical trial endpoints will be discussed. Innovative study designs for rare diseases and partnering with stakeholders will be highlighted. Junior investigators will be invited to participate in special sessions regarding career development and funding opportunities. Patients and families will have the opportunity to participate in “Meet the Expert” sessions. \nAlso\, on the agenda: \n\nMucous Rheology & Mucus Clearance\nAirway Inflammation and Oxidative Stress\nMicrobiome and Respiratory Infection\nDysregulated Immunity (Innate and Adaptive)\nLung function: Spirometry & Lung Clearance Index\n\n8.75 AMA PRA Category 1 Credits™ – maximum \nVenue: Children’s Hospital Colorado
URL:https://www.pulmapp.com/event/rare-genetic-causes-of-bronchiectasis-paving-the-way-for-interventional-trials/
LOCATION:Children\, Aurora\, CO\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2021/08/CHOC.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210930
DTEND;VALUE=DATE:20211001
DTSTAMP:20260412T084625
CREATED:20210615T115732Z
LAST-MODIFIED:20250802T004433Z
UID:15144-1632960000-1633046399@www.pulmapp.com
SUMMARY:Deconstructing Difficult-to-Treat Asthma in the Age of Targeted Biologic Therapies
DESCRIPTION:Severe asthma is defined as uncontrolled asthma despite optimal therapy and appropriate management of comorbidities; it affects up to 10% of adults with asthma\nIt is now broadly classified into 2 distinct endotypes based on the level of Th2-mediated inflammation:\n\nT2-high asthma is driven first by epithelial alarmins\, including IL-25\, IL-33\, and TLSP\, then by Th2-cytokines\, namely IL-4\, IL-5\, and IL-13\, and may include either a robust eosinophil or allergic response\nIn contrast\, T2-low asthma is driven by Th1 and Th17 cells\, IL-6\, IL-8 and IL-17\, and a neutrophilic or paucigranulocytic response\n\n\nTargets for biologic therapy for T2-high asthma include IgE\, the IL-5 signaling pathway\, and the IL-4R\n\nOmalizumab targets circulating IgE\nMepolizumab and reslizumab target circulating IL-5\nBenralizumab targets the α subunit of the IL-5R\nDupilumab targets the α subunit of the IL-4R\, which is involved in IL-4 and IL-13 signaling\n\n\nClinically relevant biomarkers for selecting a biologic agent include serum IgE level (omalizumab)\, blood eosinophil level (all 5 agents)\, and fraction of exhaled nitric oxide or FeNO (omalizumab and dupilumab)\nPatients with OCS-dependent asthma are also considered to have T2-high asthma; dupilumab is approved for this indication\, and other biologics have demonstrated efficacy in such patients as well\nCurrently no targeted therapies are approved for T2-low asthma; tiotropium\, macrolide antibiotics\, bronchial thermoplasty\, and/or low-dose OCS may be considered
URL:https://www.pulmapp.com/event/deconstructing-difficult-to-treat-asthma-in-the-age-of-targeted-biologic-therapies/
LOCATION:Online
CATEGORIES:Asthma
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/06/Email-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210930
DTEND;VALUE=DATE:20211004
DTSTAMP:20260412T084625
CREATED:20210827T092337Z
LAST-MODIFIED:20210827T092337Z
UID:15179-1632960000-1633305599@www.pulmapp.com
SUMMARY:Eastern Pulmonary Conference
DESCRIPTION:EPC blends the interactivity characteristic of small regional conferences together with the cutting edge science characteristic of large national meetings. The educational goal is to share clinically relevant information which improves the diagnostic accuracy and the effectiveness of treatments with practitioners who treat pulmonary diseases. \nOn the agenda: \n\nUpdate on cough guidelines\nMolecular phenotyping of asthma\nAlarmins: Gateway to inflammation\nTreatment and “overtreatment” of hypoxemic respiratory failure\nUpdate on nosocomial pneumonia\nLiberation from mechanical ventilation in critically ill adults\nAntibiotic resistance: Issues for the intensivist and pulmonologist\nPBL – Uncontrolled asthma: Gaining control\nPro/Con debate: Are short-acting beta agonists obsolete? The GINA Model\nAir travel and the pulmonary patient\nHypersensitivity pneumonitis: Current concepts of pathogenesis & potential treatment targets\nAntifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis\nInterstitial Lung Disease (ILD)\nEvolution of PF: From ILA’s to UIIP and everything in between\nPro/Con: Redefining the diagnosis of COPD\nLung nodules: Approaches to integrate imaging\, biomarkers\, risk and guidelines\nResilience during the COVID -19 Pandemic\nTHORACIC POCUS: Current trends and perspectives of point of care ultrasound\nCOVID-19: Lessons clinicians have learned from the pandemic\nAdvances in Nontuberculous Mycobacterial Lung Disease: Improvement in Diagnosis\, Treatment and Patient Quality of Life\nUpdate on Anti-PD-1 Targeted Therapies for the Management of Patients with NSCLC\nPulmonary Arterial Hypertension Management
URL:https://www.pulmapp.com/event/eastern-pulmonary-conference-2/
LOCATION:The Breakers Palm Beach\, 1 S County Rd\,\, Palm Beach\, Florida\, 33480
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211007
DTEND;VALUE=DATE:20211010
DTSTAMP:20260412T084625
CREATED:20210827T085604Z
LAST-MODIFIED:20210827T085604Z
UID:15165-1633564800-1633823999@www.pulmapp.com
SUMMARY:Pulmonary Manifestations of Connective Tissue Disorders
DESCRIPTION:Mayo Clinic’s Pulmonary Manifestations of Connective Tissue Disorders at the Ritz-Carlton in Orlando\, Florida is a three-day CME course designed to provide pulmonologists\, rheumatologists\, internists and general practitioners up-to-date information on pulmonary manifestations of rheumatologic disorders. From this course\, participants discern how to recognize and diagnose interstitial lung disease\, pulmonary hypertension and other respiratory problems which are common in autoimmune rheumatologic disorders\, and review the latest information regarding pathogenic mechanisms\, clinical trials and therapeutic modalities. The speakers are nationally and internationally recognized specialists in the field. Residents and fellows have the opportunity to participate by submitting original studies for poster presentations.
URL:https://www.pulmapp.com/event/pulmonary-manifestations-of-connective-tissue-disorders/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/Mayo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211017
DTEND;VALUE=DATE:20211221
DTSTAMP:20260412T084625
CREATED:20210827T092742Z
LAST-MODIFIED:20210827T092742Z
UID:15182-1634428800-1640044799@www.pulmapp.com
SUMMARY:CHEST 2021 Annual Meeting
DESCRIPTION:Expert faculty presentations\, simulated learning experiences\, education games\, and much more will be available to all participants. As always\, CHEST 2021 will be team-focused\, giving participants the opportunity to learn and improve their skill sets as a team. Health care providers in all stages of their careers will benefit from knowledge updates and clinical research presentations. An amazing opportunity to network and reconnect with colleagues.
URL:https://www.pulmapp.com/event/chest-2021-annual-meeting/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/04/CHEST-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211027
DTEND;VALUE=DATE:20211028
DTSTAMP:20260412T084625
CREATED:20211028T060047Z
LAST-MODIFIED:20250802T004230Z
UID:15225-1635292800-1635379199@www.pulmapp.com
SUMMARY:44th Annual Pulmonary and Allergy Update at Keystone
DESCRIPTION:
URL:https://www.pulmapp.com/event/44th-annual-pulmonary-and-allergy-update-at-keystone/
LOCATION:Keystone Conference Center\, Keystone\, CO
CATEGORIES:Allergies
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/National-Jewish-Health.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211104
DTEND;VALUE=DATE:20211106
DTSTAMP:20260412T084625
CREATED:20210827T093055Z
LAST-MODIFIED:20210827T093055Z
UID:15183-1635984000-1636156799@www.pulmapp.com
SUMMARY:2021 Nontuberculous Mycobacteria (NTM) Lecture Series for Providers
DESCRIPTION:Topics: \n\nEpidemiology of NTM\nEnvironmental Sources of NTM\nGenomic Approaches to Investigate Nontuberculous Mycobacteria\nHost Susceptibility\nChallenging Cases\nMycobacterial lab\nRadiologic Evaluation of Pulmonary NTM Infections\nTreatment of Slow Growing Mycobacteria\nTreatment of Rapidly Growing Mycobacteria\nSurgical Management\nEmerging therapies in NTM Pulmonary Disease\nDrug Side Effects\nBronchiectasis\nCystic Fibrosis Related NTM Infections\nExtrapulmonary NTM
URL:https://www.pulmapp.com/event/2021-nontuberculous-mycobacteria-ntm-lecture-series-for-providers/
LOCATION:National Jewish\, Molly Blake Conference Center\, Denver\, CO\, United States
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/National-Jewish-Health.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211104
DTEND;VALUE=DATE:20211106
DTSTAMP:20260412T084625
CREATED:20210827T093354Z
LAST-MODIFIED:20210827T093354Z
UID:15185-1635984000-1636156799@www.pulmapp.com
SUMMARY:
DESCRIPTION:Experts in pulmonology and critical care medicine from the University of Michigan Medical School will present a two-day virtual program for physicians and allied health care professionals that outlines the most current treatment information for patients with pulmonary complications. Combining case-based information\, research studies\, and common practice\, presentations and hands-on workshops will focus on airway procedures\, sleep medicine\, and challenges seen in critical care. After this activity\, participants will recognize and manage post intensive care syndrome. \nOn the agenda: \n\nManagement of Chronic Hypercarbic Respiratory Failure\nUpdate in Lung Cancer: What Do We Pulmonologists Need to Know?\nUpdate in Interventional Pulmonology Burden of Early COPD\nUpdates to the Asthma Guidelines and New Approaches to Managing Asthma\nRespiratory Health in a Changing Climate\nInterstitial Lung Disease: A Multi-Disciplinary Discussion\nInnovation in the Time of COVID-19\nCOVID ARDS: Themes and Descants\nThe Problems of Winning: Getting Patients Ready for Life After the ICU\nUpdates in Sepsis\nThe Lost Airway: Prevention & Management\nMAP-ping a Course Out of Shock: Best Practices in Vasopressor Use\nNeurologic Emergencies in the ICU\n\n8 AMA PRA Category 1 Credits™ – maximum \n8 ABIM MOC points
URL:https://www.pulmapp.com/event/15185/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/08/michigan.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211112
DTEND;VALUE=DATE:20211113
DTSTAMP:20260412T084625
CREATED:20211028T054307Z
LAST-MODIFIED:20250802T004422Z
UID:15205-1636675200-1636761599@www.pulmapp.com
SUMMARY:Asthma Education Summit 2021
DESCRIPTION:This activity will gather health care providers\, community members\, school representatives\, and other community-based organizations for the purpose of disseminating asthma information and promoting asthma education.\n\n\n\n\n\nTarget Audience\n\n\n\nThis activity is designed for physicians\, healthcare professionals\, school representatives and community-based organizations dedicated to the identification and treatment of asthma.\n\n\n\n\n\nLearning Objectives\n\n\n\nAt the conclusion of this activity\, participants will be able to: \n\n\nState how comorbid asthma affects other health issues;\n\n\nDescribe how environmental factors impact asthma;\n\n\nIdentify modifying factors that can help children mitigate the impact of environmental factors on asthma;\n\n\nRecall how vaping impacts youth with asthma and the resources available reduce its negative effects;\n\n\nDiscuss the benefits of conducting and participating in research and how to recruit research participants.
URL:https://www.pulmapp.com/event/asthma-education-summit-2021/
LOCATION:Virtual
CATEGORIES:Asthma
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/10/Chic-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211112
DTEND;VALUE=DATE:20211113
DTSTAMP:20260412T084625
CREATED:20211028T054626Z
LAST-MODIFIED:20211028T054626Z
UID:15208-1636675200-1636761599@www.pulmapp.com
SUMMARY:14th Annual Earl E. Bakken Symposium 2021: Cardiopulmonary Thromboembolic Disease: Insights and Innovations
DESCRIPTION:This symposium will be offered as a hybrid (in-person or virtual via Zoom webinar) experience due to COVID-19 pandemic spread. \nOn the agenda: \n\nEtiology\, Acute Assessment\, and Anticoagulation Strategies\nSurgical Approaches and Innovation for Acute PE\nInterventional Radiology in Acute PE\nPathogenesis of CTEPH: Insights from Large Animal Models\nDiagnosis and Medical Management of CTEPH\nPulmonary Balloon Angioplasty of CTEPH: Past\, Present\, and Future\nPulmonary Thromboendarterectomy for CTEPH: Past\, Present\, and Future\nECMO and Intubation Steroids\, Bethesda Experience\nECMO and North-South Syndrome\nLung Transplantation and COVID-19\n\n6 AMA PRA Category 1 Credits™ – maximum
URL:https://www.pulmapp.com/event/14th-annual-earl-e-bakken-symposium-2021-cardiopulmonary-thromboembolic-disease-insights-and-innovations/
LOCATION:McNamara Alumni Center or Live Zoom Webinar\, Minneapolis\, Minnesota
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/10/Min.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Krasnoyarsk:20211114T080000
DTEND;TZID=Asia/Krasnoyarsk:20211114T150000
DTSTAMP:20260412T084625
CREATED:20211109T171317Z
LAST-MODIFIED:20211109T173903Z
UID:15253-1636876800-1636902000@www.pulmapp.com
SUMMARY:2021 PCE Pulmonary Bootcamp
DESCRIPTION:  \nPCE PULMONARY BOOTCAMP\n\nSunday\, November 14\, 2021\n10:00 am ET | 9:00 am CT | 7:00 am PT \nABOUT THIS CE/CME LIVE STREAM\nKeep your pulmonary practice up to date! Get the latest insights into managing diseases of the respiratory tract from a panel of national expert faculty as they bring you the latest updates and clinical perspectives on management of asthma\, COPD\, pulmonary arterial hypertension\, and excessive daytime sleepiness in obstructive sleep apnea. Created specifically for the clinical needs of NPs and PAs in pulmonary medicine\, with practical perspectives and case study reviews. Live streamed for your convenience—all from the comfort of your home or office. \n\nTOPICS INCLUDE\nAsthma\, COPD\, Excessive Daytime Sleepiness\, and Pulmonary Arterial Hypertension\nRegistered Participants—Submit your case studies and have them discussed by our panel of experts! \n\n 
URL:https://www.pulmapp.com/event/2021-pce-pulmonary-bootcamp/
LOCATION:TN
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211129
DTEND;VALUE=DATE:20211203
DTSTAMP:20260412T084625
CREATED:20211028T054910Z
LAST-MODIFIED:20211028T054910Z
UID:15212-1638144000-1638489599@www.pulmapp.com
SUMMARY:WASOG (World Association for Sarcoidosis and Other Granulomatous Disorders) / AASOG (Proceedings of the Americas Association of Sarcoidosis and Other Granulomatous Diseases) 2021: Multidisciplinary Meeting for Sarcoidosis and ILD
DESCRIPTION:WASOG/AASOG 2021\nThe scientific program of the conference includes the latest information regarding the pathogenesis\, diagnosis and treatment of sarcoidosis and interstitial lung diseases. International recognized experts will share their experience with us during this 4-day\, live stream scientific event. \nBy attending this conference\, participants will be able to:\n\nSummarize the evidence on managing patients with fibrotic interstitial lung disease including diagnostic techniques and antifibrotic and immunosuppressive therapies.\nClinically review the diagnostic dilemmas\, utility of diagnostic testing\, and usefulness of therapies to identify and manage cardiac sarcoidosis.\nDescribe how granulomatous and nongranulomatous inflammation leads to fibrosis.\nReview the current knowledge of genetics and genomics in sarcoidosis and interpret its implications for clinical practice.\nReview efficacy and side effect profiles for treatments used to manage sarcoidosis.\nDefine disability in sarcoidosis using WASOG criteria and describe instruments for assessment\, survey results\, and occupational medicine perspectives.\nSummarize the most recent data affecting clinical practice for patients with sarcoidosis.\n\nWhy Join the Live Stream?\n\nLearn about cutting-edge advances in parenchymal lung disease and cardiac sarcoidosis\nParticipate in discussion-focused format with ample time for live question and answer sessions\nConnect with faculty during our consult the professor session to solve clinical conundrums\nNetwork with fellow participants and faculty during breaks through our virtual platform\nJoin an interdisciplinary audience of practitioners and healthcare professionals who seek to learn the latest developments in sarcoidosis and interstitial lung diseases\nCan’t attend the live stream? Registrants receive access to the recordings\, post-course\n\nWho Should Attend?\nPractitioners and healthcare professionals who seek to learn the latest developments in sarcoidosis and interstitial lung diseases\, including pulmonologists\, cardiologists\, pulmonary critical care specialists\, nurse practitioners\, residents and fellows.
URL:https://www.pulmapp.com/event/wasog-world-association-for-sarcoidosis-and-other-granulomatous-disorders-aasog-proceedings-of-the-americas-association-of-sarcoidosis-and-other-granulomatous-diseases-2021-multidisciplinary-me/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2021/10/CC.jpg
END:VEVENT
END:VCALENDAR